Researchers at Massachusetts Eye and Ear/Harvard Medical School and Boston University have successfully shown neuroprotection in a Parkinson’s mouse model using new techniques to deliver drugs across the naturally impenetrable blood-brain barrier. Their findings, published in Neurosurgery, lend hope to patients around the world with neurological conditions that are difficult to treat due to a barrier mechanism that prevents approximately 98 percent of drugs from reaching the brain and central nervous system.
“We are developing a platform that may eventually be used to deliver a variety of drugs to the brain,” said senior author Benjamin S. Bleier, M.D. (in photo), of the department of otolaryngology at Mass. Eye and Ear/Harvard Medical School. “Although we are currently looking at neurodegenerative disease, there is potential for the technology to be expanded to psychiatric diseases, chronic pain, seizure disorders and many other conditions affecting the brain and nervous system down the road.”
Using nasal mucosal grafting, researchers delivered glial derived neurotrophic factor (GDNF), a therapeutic protein in testing for treating Parkinson’s disease, to the brains of mice. They showed through behavioral and histological data capture that their delivery method was equivalent to direct injection of GDNF – the current gold standard for delivering this drug in Parkinson’s disease despite its traumatic nature and high complication rates – in diffusing drugs to the brain.
The researchers chose to test their delivery method with GDNF because the therapy has been shown to delay and even reverse disease progression of Parkinson’s disease in pre-clinical models. The study was funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF).
“Brain diseases are notoriously difficult to treat due to the natural protections the body builds against intrusion,” said Jamie Eberling, Ph.D., senior associate director of MJFF research programs. “Dr. Bleier’s group has identified a potential avenue to pass that barrier, and we look forward to the next stage of research to further test its utility in people with Parkinson’s disease .”
Nasal mucosal grafting is a technique regularly used in the ENT field to reconstruct the barrier around the brain after surgery to the skull base. ENT surgeons commonly use endoscopic approaches to remove brain tumors through the nose by making a window through the blood-brain barrier to access the brain. Once they have finished the treatment, they use adjacent nasal lining to rebuild the hole in a permanent and safe way. The safety and efficacy of these methods have been well established through long-term clinical outcomes studies in the field, with the nasal lining protecting the brain from infection just as the blood brain barrier has done.
Dr. Bleier saw an opportunity to apply these techniques to the widespread clinical dilemma of delivering drugs across the barrier to the brain and central nervous system. By functionally replacing a section of the blood-brain barrier with nasal mucosa, which is more than 1,000 times more permeable than the native barrier, surgeons may create a “screen door” to allow for drug delivery to the brain and central nervous system.
The technique has the potential to benefit a large population of patients with neurodegenerative disorders, where there remains a specific unmet need for blood-brain penetrating therapeutic delivery strategies.
“We see this expanding beyond Parkinson’s disease, as there are multiple diseases of the brain that do not have good therapeutic options,” Dr. Bleier said. “It is a platform that opens doors for new discovery and could enable drug development for an underserved population.”
The Latest on: neurodegenerative disorders
[google_news title=”” keyword=”neurodegenerative disorders” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: neurodegenerative disorders
- Decoding Parkinson’s disease: New genetic variant offers hope for future treatmentson April 26, 2024 at 1:00 pm
Researchers have discovered a new genetic variant, RAB32 Ser71Arg, linked to Parkinson's disease across several countries. This variant interacts with proteins affecting dopamine levels and cell ...
- Synthetic nanomaterial could be an effective tool for treating neurodegenerative diseaseson April 26, 2024 at 1:44 am
A newly developed nanomaterial that mimics the behavior of proteins could be an effective tool for treating Alzheimer's and other neurodegenerative diseases.
- Diet's impact on gut bacteria offers new clues in Parkinson's disease managementon April 25, 2024 at 6:35 pm
Researchers find that diet significantly influences the gut microbiome in Parkinson's disease patients, potentially affecting disease progression and symptoms.
- Contaminated deer meat may have caused 2 hunters' deadly brain diseaseson April 25, 2024 at 11:28 am
A new report calls for further study into a possible link between chronic wasting disease in deer and a rare and deadly brain disease in humans.
- Nanomaterial that mimics proteins could be basis for new neurodegenerative disease treatmentson April 25, 2024 at 9:25 am
A newly developed nanomaterial that mimics the behavior of proteins could be an effective tool for treating Alzheimer's and other neurodegenerative diseases. The nanomaterial alters the interaction ...
- Scientists Discover Key to Unlocking the Secret of Degenerative Brain Disorders Like Alzheimer’son April 23, 2024 at 8:05 pm
Scientists have developed 'NeuM', a neuron labeling technology enabling detailed observation of neuronal structure. Successful monitoring of neuronal changes for up to 72 hours. Alzheimer's disease, ...
- New disease models unlocking secrets to neurological researchon April 23, 2024 at 9:28 am
Another major technological advancement has been the proliferation of microfluidic devices, which contain a small chip, imprinted with very small channels and reaction chambers, that uses forces such ...
- Magnetic microcoils unlock targeted single-neuron therapies for neurodegenerative disorderson April 23, 2024 at 8:00 am
Neural stimulation is a medical technique used to treat many illnesses affecting the nervous system. It involves applying energy to neurons to encourage them to grow and make connections with their ...
- Parkinson’s Disease: Age Isn’t the Sole Factor- Expert Explains Risk Factors Of The Neurodegenerative Illnesson April 23, 2024 at 5:31 am
The intricate interaction between age, genetics, and environmental factors leads to Parkinsons disease. Read more about the disease, here.
- Brain benefits: How exercise improves your mood and protects against neurodegenerative diseaseson April 21, 2024 at 10:01 pm
Physical activity is excellent for your brain, with benefits including protection against neurodegenerative diseases ...
via Bing News